{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:23Z","timestamp":1792801463468,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MSA Coalition","award":["243335"],"award-info":[{"award-number":["243335"]}]},{"name":"Lizanell and Colbert Coldwell Foundation","award":["243036"],"award-info":[{"award-number":["243036"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.01.028","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T04:16:34Z","timestamp":1485836194000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["FTY720 (Fingolimod) reverses \u03b1-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells"],"prefix":"10.1016","volume":"117","author":[{"given":"Ismael","family":"Segura-Ulate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vargas-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.01.028_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/elps.201100335","article-title":"Bleach gel: a simple agarose gel for analyzing RNA quality","volume":"33","author":"Aranda","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/cib.3.2.10964","article-title":"The regulation of synaptic function by alpha-synuclein","volume":"3","author":"Bellani","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.107.123927","article-title":"The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors","volume":"323","author":"Coelho","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/glia.22688","article-title":"Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors","volume":"62","author":"Cui","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib5","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","article-title":"Alpha-synuclein expression in the oligodendrocyte lineage: an in\u00a0vitro and in\u00a0vivo study using rodent and human models","volume":"5","author":"Djelloul","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib8","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1038\/tp.2015.179","article-title":"Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory","volume":"5","author":"Efstathopoulos","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib9","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","article-title":"alpha-synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton","volume":"26","author":"Esposito","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mcn.2014.06.012","article-title":"Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells","volume":"62","author":"Ettle","year":"2014","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib12","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1007\/s12035-015-9205-3","article-title":"Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders?","volume":"53","author":"Ettle","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib13","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel Parkinson's disease linked mutation G51D attenuates in\u00a0vitro aggregation and membrane binding of alpha-synuclein, and enhances its secretion and nuclear localization in cells","volume":"23","author":"Fares","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions","volume":"65","author":"Fukuchi","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib15","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1021\/bi5010365","article-title":"The newly discovered Parkinson's disease associated finnish mutation (A53E) attenuates alpha-synuclein aggregation and membrane binding","volume":"53","author":"Ghosh","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.mp.4000458","article-title":"Lewy body diseases and multiple system atrophy as alpha-synucleinopathies","volume":"3","author":"Goedert","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib18","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi0341152","article-title":"Nuclear localization of alpha-synuclein and its interaction with histones","volume":"42","author":"Goers","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn.3728","article-title":"Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory","volume":"17","author":"Hait","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib20","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1038\/oncsis.2015.16","article-title":"The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERalpha expression and enhances hormonal therapy for breast cancer","volume":"4","author":"Hait","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2015.05.002","article-title":"Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype","volume":"271","author":"Heinen","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib23","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.26052","article-title":"Neuropathology of multiple system atrophy: new thoughts about pathogenesis","volume":"29","author":"Jellinger","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/glia.20576","article-title":"Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells","volume":"55","author":"Jung","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00005072-199907000-00010","article-title":"Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy","volume":"58","author":"Kawamoto","year":"1999","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib26","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1093\/nar\/gkq170","article-title":"Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region","volume":"38","author":"Khobta","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2013.11.009","article-title":"Alpha-synuclein interferes with cAMP\/PKA-dependent upregulation of dopamine beta-hydroxylase and is associated with abnormal adaptive responses to immobilization stress","volume":"252","author":"Kim","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib29","doi-asserted-by":"crossref","first-page":"e46817","DOI":"10.1371\/journal.pone.0046817","article-title":"Increased neuronal alpha-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling alpha-synucleinopathies","volume":"7","author":"Kisos","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib30","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nn.3932","article-title":"Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area","volume":"18","author":"Koo","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuropharm.2013.07.035","article-title":"The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle","volume":"82","author":"Ma","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood-2014-02-553792","article-title":"Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells","volume":"124","author":"Makarona","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib34","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","article-title":"alpha-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy","volume":"35","author":"May","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib35","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1740925X04000043","article-title":"Glial cell inclusions and the pathogenesis of neurodegenerative diseases","volume":"1","author":"Miller","year":"2004","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib37","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","article-title":"Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia","volume":"112","author":"Miller","year":"2005","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ana.21227","article-title":"FTY720 modulates human oligodendrocyte progenitor process extension and survival","volume":"63","author":"Miron","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib39","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2353\/ajpath.2010.091234","article-title":"Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices","volume":"176","author":"Miron","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/mds.20491","article-title":"Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy","volume":"20","author":"Nishimura","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"2180","key":"10.1016\/j.neuropharm.2017.01.028_bib43","first-page":"e2181","article-title":"Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib44","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A\u00a0role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib45","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12031-013-0154-x","article-title":"Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular alpha-synuclein in oligodendrocytes","volume":"52","author":"Pukass","year":"2014","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/glia.22611","article-title":"Alpha-synuclein transfers from neurons to oligodendrocytes","volume":"62","author":"Reyes","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib48","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.freeradbiomed.2012.05.024","article-title":"Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1353-8020(99)00031-0","article-title":"Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies","volume":"5","author":"Spillantini","year":"1999","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: parkinson's disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nan.12304","article-title":"Review: multiple system atrophy: emerging targets for interventional therapies","volume":"42","author":"Stefanova","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2009.05175.x","article-title":"Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons","volume":"1199","author":"Tian","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1541-7786.MCR-07-0175","article-title":"Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells","volume":"6","author":"To","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib55","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","article-title":"Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors","volume":"30","author":"Ubhi","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.expneurol.2012.01.008","article-title":"Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of alpha-synucleinopathy","volume":"234","author":"Ubhi","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib57","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/ml500128g","article-title":"Novel FTY720-based compounds stimulate neurotrophin expression and phosphatase activity in dopaminergic cells","volume":"5","author":"Vargas-Medrano","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib58","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s11064-010-0318-9","article-title":"Glial cell lines: an overview","volume":"35","author":"De Vries","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib60","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib61","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.2012.07871.x","article-title":"Extracellular signal-regulated kinase 1\/2 signaling promotes oligodendrocyte myelination in\u00a0vitro","volume":"122","author":"Xiao","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.028_bib63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10571-010-9523-y","article-title":"Overexpression of alpha-synuclein down-regulates BDNF expression","volume":"30","author":"Yuan","year":"2010","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib64","doi-asserted-by":"crossref","first-page":"17800","DOI":"10.1523\/JNEUROSCI.3878-11.2011","article-title":"Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging","volume":"31","author":"Zeng","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2015.01.006","article-title":"Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis","volume":"76C","author":"Zhang","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib66","doi-asserted-by":"crossref","first-page":"39155","DOI":"10.1074\/jbc.M405456200","article-title":"Analysis of alpha-synuclein-associated proteins by quantitative proteomics","volume":"279","author":"Zhou","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.028_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2013.01.024","article-title":"Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress","volume":"1500","author":"Zhou","year":"2013","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T19:10:52Z","timestamp":1587409852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":67,"alternative-id":["S0028390817300291"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.028","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTY720 (Fingolimod) reverses \u03b1-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}